UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010829
Receipt number R000012683
Scientific Title Effects of anti-allergic rhinitis treatment on adherence to nasal positive airway pressure therapy
Date of disclosure of the study information 2013/05/29
Last modified on 2015/05/08 10:46:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of anti-allergic rhinitis treatment on adherence to nasal positive airway pressure therapy

Acronym

allegic rhinitis and nasal positive airway pressure therapy

Scientific Title

Effects of anti-allergic rhinitis treatment on adherence to nasal positive airway pressure therapy

Scientific Title:Acronym

allegic rhinitis and nasal positive airway pressure therapy

Region

Japan


Condition

Condition

obstructive sleep apnea syndrome

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effects of anti allergic medication on patients with sleep apnea syndrome (SAS) amd allegic rhinitis are investigated in terms of adherence to continuous positive airway pressure (CPAP) therapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

hours of using CPAP per day

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

administration of montelukast or loratadine

Interventions/Control_2

seasonal or chronic allergic rhinitis

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

patients with sleep apnea syndrome treated by CPAP and comorbid allergic rhinitis

Key exclusion criteria

patients with nasal polyp or tumor
patients with a history of nose surgery within the past 3 years

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kaoru Ogawa

Organization

keio University School of Medicine

Division name

Otolaryngology- head and neck surgery

Zip code


Address

35 Shinanomachi, Shinjuku

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Keio University School of Medicine

Division name

Institutional Review Board

Zip code


Address


TEL


Homepage URL

http://www.ccr.med.keio.ac.jp/rinri/index.html

Email



Sponsor or person

Institute

Keio University School of Medicine, Department of Otolaryngology

Institute

Department

Personal name



Funding Source

Organization

MSD K.K.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2010 Year 11 Month 22 Day

Date of IRB


Anticipated trial start date

2010 Year 12 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 05 Month 29 Day

Last modified on

2015 Year 05 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012683


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name